# Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy

> **NCT04935333** · — · UNKNOWN · sponsor: **Igenomix** · enrollment: 600 (estimated)

## Conditions studied

- Leiomyoma, Uterine
- Leiomyosarcoma Uterus

## Interventions

- **PROCEDURE:** Collection of Leiomyoma samples
- **PROCEDURE:** Collection of Leiomyosarcoma samples
- **PROCEDURE:** Collection of control samples

## Key facts

- **NCT ID:** NCT04935333
- **Lead sponsor:** Igenomix
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935333, "Accuracy of the Preoperative Molecular Diagnosis of Uterine Tumors by Liquid Biopsy". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04935333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*